Q1 2026 Holdings
Filed 2026-05-15 | 73 holdings | $175.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $6.0K | 18,176 | 0.0% |
| Docgo Inc(DCGO) | COM | 256086109 | $24.9K | 39,573 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $41.0K | 17,503 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $119.8K | 14,300 | 0.1% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $132.0K | 20,000 | 0.1% |
| Kyntra BIO Inc(KYNB) | COM NEW | 31572Q881 | $153.0K | 22,566 | 0.1% |
| Elutia Inc(ELUT) | COM | 05479K106 | $173.3K | 165,094 | 0.1% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $231.5K | 50,000 | 0.1% |
| Kayne Anderson BDC Inc(KBDC) | COM SHS | 48662X105 | $274.4K | 20,000 | 0.2% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $284.2K | 20,000 | 0.2% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $289.2K | 74,918 | 0.2% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $294.0K | 60,000 | 0.2% |
| Trinity Cap Inc(TRIN) | COM | 896442308 | $294.2K | 20,000 | 0.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $316.7K | 12,900 | 0.2% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $322.8K | 250,221 | 0.2% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $379.7K | 98,882 | 0.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $393.2K | 20,100 | 0.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $454.8K | 127,025 | 0.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $467.6K | 83,952 | 0.3% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $555.3K | 66,270 | 0.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $559.2K | 25,889 | 0.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $561.8K | 16,860 | 0.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $563.2K | 14,000 | 0.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $645.2K | 8,688 | 0.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $652.8K | 10,100 | 0.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $757.5K | 9,000 | 0.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $795.0K | 150,000 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $843.2K | 29,847 | 0.5% |
| Harrow Health Inc(HROW) | COM | 415858109 | $846.2K | 24,000 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $867.5K | 29,200 | 0.5% |
| Lipocine Inc(LPCN) | COM NEW | 53630X203 | $893.2K | 111,786 | 0.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $916.7K | 5,000 | 0.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.0M | 6,000 | 0.6% |
| Freeport-Mcmoran CL(FCX) | CL-B | 35671D857 | $1.1M | 18,040 | 0.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $1.1M | 50,000 | 0.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.1M | 57,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.2M | 21,000 | 0.7% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $1.3M | 62,000 | 0.7% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.3M | 281,730 | 0.8% |
| Quidelortho Corp | COM | 74838J101 | $1.4M | 82,548 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $1.4M | 70,000 | 0.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.6M | 100,697 | 0.9% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $1.7M | 250,000 | 1.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.8M | 50,000 | 1.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.8M | 44,000 | 1.0% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.9M | 47,200 | 1.1% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $2.0M | 30,000 | 1.1% |
| Pacific Biosciences of California Inc(PACB) | COM | 69404D108 | $2.0M | 1,500,000 | 1.1% |
| Compass Pathways LTD(CMPS) | SPONSORED ADS | 20451W101 | $2.1M | 375,000 | 1.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.2M | 463,599 | 1.2% |